A retrospective study of daratumumab in different regimens in Portuguese patients with relapsed/refractory multiple myeloma
Latest Information Update: 03 Aug 2021
At a glance
- Drugs Daratumumab (Primary) ; Bortezomib; Dexamethasone; Lenalidomide
- Indications Multiple myeloma
- Focus Therapeutic Use
- 03 Aug 2021 New trial record
- 17 Jun 2021 Results presented at the 26th Congress of the European Haematology Association